Non Invasive Prenatal Testing Market

Non Invasive Prenatal Testing Market Size, Share, Growth Analysis, By Gestation Period(0-12 Weeks, 13-24 Weeks, 25-36 Weeks), By Pregnancy Risk(High & Average Risk, Low Risk), By Method(Ultrasound Detection, Biochemical Screening Tests, Cell-free DNA in Maternal Plasma Tests), By Technology(NGS, Array Technology, PCR, Others), By Product(Consumables & Reagents, Instruments), By Application(Trisomy, Microdeletion Syndrome, Other Applications), By End-use(Hospitals & Clinics, Diagnostic Laboratories), By Regional(North America, Europe, Asia Pacific, Latin America) - Industry Forecast 2025-2032


Report ID: UCMIG35A2459 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Non Invasive Prenatal Testing Market Insights

Market Overview:

The global market for non-invasive prenatal testing (NIPT) reached a significant value of USD 3.80 billion in 2022. It is projected to experience a robust compound annual growth rate (CAGR) of 9.61% during the forecast period from 2023 to 2030. This growth can be attributed to the increasing adoption of NIPT by pregnant women and Health Care providers due to its non-invasive nature and high accuracy in detecting fetal chromosomal abnormalities. Additionally, advancements in technology and the availability of a wide range of tests for detecting various genetic disorders further contribute to the market's expansion. As the demand for safer and more reliable prenatal testing methods continues to rise, the global non-invasive prenatal testing market is expected to witness substantial growth in the coming years.

Non Invasive Prenatal Testing Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Health Care Equipment by segment aggregation, the contribution of the Health Care Equipment in Health Care Equipment & Services and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for Non Invasive Prenatal Testing was estimated to be valued at US$ XX Mn in 2021.

The Non Invasive Prenatal Testing Market is estimated to grow at a CAGR of XX% by 2028.

The Non Invasive Prenatal Testing Market is segmented on the basis of Gestation Period, Pregnancy Risk, Method, Technology, Product, Application, End-use, Regional.

Based on region, the Non Invasive Prenatal Testing Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the Non Invasive Prenatal Testing Market are Genesis Genetics (CooperSurgical, Inc.), Natera, Inc., Centogene N.V., Illumina, Inc. (Verinata Health, Inc.), Eurofins LifeCodexx GmbH, MedGenome Labs Ltd., F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics), Myriad Women’s Health, Inc. (Counsyl, Inc.), Progenity, Inc., Qiagen, Laboratory Corp. of America Holdings, Quest Diagnostics, Inc..

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Non Invasive Prenatal Testing Market

Report ID: UCMIG35A2459

$5,300
BUY NOW GET FREE SAMPLE